MedPath

Treatment of C. Difficile Infection With Fecal Microbiota Transplantation (FMT)

Not Applicable
Withdrawn
Conditions
Clostridium Difficile Infection
Registration Number
NCT01842347
Lead Sponsor
Medical College of Wisconsin
Brief Summary

The purpose of this study is to treat children with severe, moderate, resistant or relapsing C. difficile infection and to determine the changes in the intestinal microbiome (all of the bacteria living in the intestines) in children receiving FMT for C. difficile infection. Data will be collected throughout the FMT procedure to determine effectiveness and to help standardize this procedure. Stool samples will be collected to look at the different bacteria that are in the intestines before and after FMT.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Treatment of C. Difficile Infection with Fecal Microbiota Transplantation (FMT)3 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Children's Hospital of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

Children's Hospital of Wisconsin
🇺🇸Milwaukee, Wisconsin, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.